This topic contains a solution. Click here to go to the answer

Author Question: Which of the following patient groups should be considered for lung expansion therapy using ... (Read 46 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
Which of the following patient groups should be considered for lung expansion therapy using intermittent positive-pressure breathing (IPPB)?
 
  1. Patients with clinically diagnosed atelectasis who are not responsive to other therapies
  2. Patients at high risk for atelectasis who cannot cooperate with other methods
  3. All obese patients who have undergone abdominal surgery
  a. 1 and 2 only
  b. 2 and 3 only
  c. 1 and 3 only
  d. 1, 2, and 3

Question 2

Correct instruction in the technique of incentive spirometry should include which of the follow-ing?
 
  a. Use of accessory muscles at high inspira-tory flows
  b. Diaphragmatic breathing at slow to mod-erate flows
  c. Panting at volumes approaching total lung capacity
  d. Use of accessory muscles at low inspira-tory flows



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amandanbreshears

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

ANS: A
IPPB may be useful for patients with clinically diagnosed atelectasis not responsive to other therapies, such as incentive spirometry and chest physiotherapy. In addition, IPPB may be useful for patients who are at high risk for atelectasis and not able to cooperate with more simple tech-niques such as IS.

Answer to Question 2

ANS: B
Correct technique calls for diaphragmatic breathing at slow-to-moderate inspiratory flows.





 

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

For a complete list of videos, visit our video library